Fiscal Wizard · Single-issue tearsheet

NTRA / May 12, 2026 Run #8

NTRA

Natera, Inc.

Diagnostics & Research

Composite verdict

F 5.2 / 100

Weak fundamentals · technicals unscored.

Industry rank 14th of 14 in Diagnostics & Research

industry=Diagnostics & Research

Fundamentals Weak

5.2 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 34 metrics shown.

Strongest
Weakest
Revenue Growth (YoY) 100
Greenblatt EY 0
Asset Turnover 70
EV/FCF 0
Days Sales Outstanding 60
Return on Capital Employed 0

Technicals Unscored

/ 100

Stand aside — active gates voided the directional signals that fired. · 26 signals shown.

Risk Gates

5 blocking 5 caution

5 gates blocking, 26 signals voided.

  • Beneish M-Score voids RSI Divergence, MACD Divergence +13
  • Interest Coverage voids RSI Divergence, MACD Divergence +13
  • ADX Trend Weakness voids Trendline Break, Donchian Breakout +3
  • MA Crossover active · no matches

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for NTRA.